SM22 aphla Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-SM22 aphla antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SM22 aphla |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.1 mL, 0.2 mL |
| Concentration | 1mg/ml |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: SM22 aphla antibody detects endogenous levels of total SM22 aphla. Description: Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence.Similarity: Belongs to the calponin family. |
| Immunogen | Immunogen: A synthesized peptide derived from human SM22 aphla Subcellular Location: Cytoplasm. Tissue Specificity: Overexpressed in senescent human fibroblasts. Predicted Cross Reactivity: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus Similarity: Pig (100%), Zebrafish (100%), Bovine (100%), Horse (100%), Sheep (100%), Rabbit (100%), Dog (100%), Chicken (100%), Xenopus (100%) |
| Other Names | [22 kDa actin binding protein; 22 kDa actin-binding protein; Human 22kDa smooth muscle protein; Protein WS3-10; SM22 alpha; SM22; SMCC; Smooth muscle protein 22-alpha; TAGL_HUMAN; TAGLN; TAGLN1; Transgelin; Transgelin variant 2; WS3 10] |
| Gene, Accession # | [SM22-alpha], Gene ID: 6876, NCBI: NP_001001522.1, UniProt: Q01995 |
| Catalog # | MBS9602283 |
| Price | $240, $280 |
| Order / More Info | SM22 aphla Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies